TrueScale Capitals leads Series B2 funding for Advamedica

Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale Capital. Existing investors Omidyar Network, University of California-Ratan N. Tata Fund and Accel also participated in the fundraising.

Advamedica which has now raised a total of more than $20 million, plans to use the fresh capital to build its commercial presence in the United States and the European Union (EU), as well as strengthen its India operations, according to a statement.

Read More

axio_admin

all author posts

Leave a Reply

Your email address will not be published. Required fields are makes.

YOU ARE LEAVING THE ADVAMEDICA US SITE.

If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”

Contact us

YOU ARE LEAVING THE ADVAMEDICA US SITE.

If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”